Poor antibody response to the first dose of the Pfizer-BioNTech vaccine for patients with chronic kidney disease

Patients with chronic kidney disease, including those on dialysis, have been prioritized for vaccination due to increased risk of severe COVID-19 outcomes such as hospitalization and death. In a CITF-funded study now published in JAMA Network Open, several CITF and VSRG-affiliated researchers, including Drs. Michelle Hladunewich and Matthew Oliver report that many dialysis patients … Continue reading Poor antibody response to the first dose of the Pfizer-BioNTech vaccine for patients with chronic kidney disease